Diagnosis. Osteoporosis, persistent after 12 years of hormone replacement therapy, and celiac disease. Management. The patient was initially treated for bone loss with postmenopausal hormone ...
When deciding which postmenopausal women under 65 to screen, the USPSTF recommended that clinicians first take stock of risk ...
The sequential administration of PTH and a bisphosphonate induces better BMD responses than any other treatment given either alone or in combination, but PTH therapy is inconvenient and costly.
the efficacy data do not clearly show that PTH should be selected over antiresorptive therapies for the treatment of osteoporosis. In addition, PTH is expensive and must be administered daily via ...
Long-term bisphosphonate treatment of postmenopausal osteoporosis is associated with reduction of bone turnover and might, therefore, have deleterious adverse effects on the repair of microdamage ...
In a final recommendation statement, the U.S. Preventive Services Task Force said that all women aged 65 years and older ...
Researchers at Hospital for Special Surgery (HSS) have pinpointed a cellular target that could enhance the way osteoporosis ...
The U.S Preventive Services Task Force (USPSTF) recommends osteoporosis screening to prevent osteoporotic fractures for all ...
Osteoporosis: Eight things everyone should know about the silent disease - One in two women over the age of 50 will break a ...
It's not easy being a woman. Just look at the statistics. Women are more likely to have such debilitating conditions as osteoporosis, migraines, Alzheimer disease, depression, multiple sclerosis, and ...
All women 65 and older should continue to be screened for osteoporosis, the nation’s leading preventive health panel ...
Osteoporosis, a condition where bones become weak and brittle, affects millions worldwide, with postmenopausal women at the ...